USPTO Examiner REYES REGINALD R - Art Unit 3626

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17128997UNTACT TREATMENT SYSTEMDecember 2020December 2023Abandon3601NoNo
17128129INTELLIGENT CONTAINER FOR MEDICINE DISPENSING CONTROLDecember 2020February 2023Allow2610NoNo
17106408METHODS AND SYSTEMS FOR SELECTING AN ALIMENTARY TRANSFER DESCRIPTOR USING CATEGORICAL CONSTRAINTSNovember 2020February 2023Allow2620YesNo
16950884UNDERPAYMENT IDENTIFICATION TOOL AND REVENUE RECOVERY PROCESSNovember 2020January 2024Abandon3821NoNo
17074194SYSTEMS AND METHODS FOR DISEASE CONTROL AND MANAGEMENTOctober 2020March 2021Allow510YesNo
17072693AUTOMATED DEVICE EFFICACY DETERMINATION SYSTEMS FOR HEALTH MONITORING DEVICESOctober 2020November 2023Allow3720NoNo
16997005SYSTEMS AND METHODS FOR SCAN PREPARATIONAugust 2020December 2023Allow4020YesNo
16945257IDENTIFYING REFERRAL PATTERNS BETWEEN HEALTHCARE ENTITIES BASED ON BILLED CLAIMSJuly 2020April 2024Abandon4520YesNo
16941686MEDICAL SCAN ARTIFACT DETECTION SYSTEM AND METHODS FOR USE THEREWITHJuly 2020June 2023Abandon3510NoNo
16941483PET INSURANCE SYSTEM AND METHODJuly 2020April 2024Allow4540YesNo
16937130HEALTH CARE PRESCRIPTION SYNCHRONIZATION BETWEEN PATIENT AND HEALTH CARE PROVIDERJuly 2020November 2022Allow2820NoNo
16931009SYSTEM AND METHOD FOR HEALTH CARE DATA INTEGRATION AND MANAGEMENTJuly 2020April 2023Abandon3320NoNo
16923883TRACKING AND QUALITY ASSURANCE OF PATHOLOGY, RADIOLOGY AND OTHER MEDICAL OR SURGICAL PROCEDURESJuly 2020April 2024Allow4530YesNo
16915186Clinic Wait-Time Visibility and ReservationsJune 2020May 2022Allow2210YesNo
16905784SYSTEM AND METHOD FOR SECURE, PRIVATE, AND TRUSTED MEDICAL INFORMATION MONITORING AND SEMI-AUTONOMOUS PRESCRIPTION MANAGEMENTJune 2020March 2024Allow4511NoNo
16887177SYSTEM AND METHOD FOR RAPID AND ACCURATE HISTOLOGIC ANALYSIS OF TUMOR MARGINS USING MACHINE LEARNINGMay 2020July 2023Allow3811YesNo
16766690METHOD FOR PREDICTING DRUG-DRUG OR DRUG-FOOD INTERACTION BY USING STRUCTURAL INFORMATION OF DRUGMay 2020October 2022Allow2910NoNo
16875013METHOD OF AND DEVICE FOR IMPLEMENTING CONTAGIOUS ILLNESS ANALYSIS AND TRACKINGMay 2020March 2021Allow1020NoNo
16854126Systems and methods for disease control and managementApril 2020October 2020Allow601NoNo
16854088ADAPTIVE ANALYTICAL BEHAVIORAL AND HEALTH ASSISTANT SYSTEM AND RELATED METHOD OF USEApril 2020October 2020Allow610YesNo
16853638TRACKING AND QUALITY ASSURANCE OF PATHOLOGY, RADIOLOGY AND OTHER MEDICAL OR SURGICAL PROCEDURESApril 2020September 2023Allow4130YesNo
16847855MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING SYSTEM, AND MEDICAL INFORMATION PROCESSING METHODApril 2020September 2024Abandon5340NoNo
16848310Systems and methods for disease control and managementApril 2020October 2020Allow610YesNo
16846996Electronic Devices and Methods for Treatment of Depressive Symptoms, Depressive Disorders Utilizing Digital TherapiesApril 2020May 2024Abandon4920YesYes
16839920GENETIC DATA ANALYSIS AND DATABASE TOOLSApril 2020March 2022Abandon2410NoNo
16824193MOBILE DEVICE-BASED SYSTEM FOR AUTOMATED, REAL TIME HEALTH RECORD EXCHANGEMarch 2020August 2020Allow510YesNo
16814131METHOD FOR MANAGING ANNOTATION JOB, APPARATUS AND SYSTEM SUPPORTING THE SAMEMarch 2020April 2021Allow1330NoNo
16637492DISEASE DEVELOPMENT RISK PREDICTION SYSTEM, DISEASE DEVELOPMENT RISK PREDICTION METHOD, AND DISEASE DEVELOPMENT RISK PREDICTION PROGRAMFebruary 2020May 2022Allow2720NoNo
16729697PROGNOSIS OF PROSTATE CANCER WITH COMPUTERIZED HISTOMORPHOMETRIC FEATURES OF TUMOR MORPHOLOGY FROM ROUTINE HEMATOXYLIN AND EOSIN SLIDESDecember 2019June 2022Allow3000NoNo
16720193INFORMATION RECORDING DEVICE, PROSTHETIC LIMB, ANALYSIS SYSTEM, INFORMATION RECORDING METHOD, AND METHOD OF SUPPORTING PURCHASE OF PRODUCTDecember 2019January 2024Allow4831YesNo
16714209SYSTEMS, METHODS, AND DEVICES FOR BIOPHYSICAL MODELING AND RESPONSE PREDICTIONDecember 2019October 2022Allow3410YesNo
16701950METHOD AND SYSTEM FOR SYNCHRONIZING MEDICAL IMAGE ANALYSIS AND REPORTINGDecember 2019January 2023Abandon3740NoNo
16700727MOBILE DEVICE-BASED SYSTEM FOR AUTOMATED, REAL TIME HEALTH RECORD EXCHANGEDecember 2019January 2023Allow3830NoNo
16698612SYSTEMS AND METHODS FOR INFERRING CELL STATUSNovember 2019December 2022Allow3601NoNo
16616664MACHINE LEARNING ON RAW MEDICAL IMAGING DATA FOR CLINICAL DECISION SUPPORTNovember 2019December 2023Allow4931YesNo
16672710BODY MANAGEMENT SYSTEMNovember 2019July 2024Abandon5741NoNo
16608900Indication Method, Indication Apparatus and Design Method for Designing the SameOctober 2019December 2022Abandon3701NoNo
16665862INTERACTIVE AND ANALYTICAL SYSTEM THAT PROVIDES A DYNAMIC TOOL FOR THERAPIES TO PREVENT AND CURE DEMENTIA-RELATED DISEASESOctober 2019November 2021Allow2410YesNo
16608642BODY COMPOSITION PREDICTION TOOLSOctober 2019March 2023Allow4130YesNo
16656090INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUMOctober 2019December 2023Abandon5031YesNo
16597408METHOD AND SYSTEM FOR CONCURRENTLY MONITORING MULTIPLE OBSTETRICS PATIENTSOctober 2019April 2022Allow3011NoNo
16588080MEDICAL IMAGING STROKE MODELSeptember 2019September 2022Allow3630YesNo
16586611MINING SENTIMENTS BY BIO-SENSING TO IMPROVE PERFORMANCESeptember 2019March 2024Abandon5330YesNo
16586860INFORMATION PROVISION METHOD, INFORMATION PROCESSING SYSTEM, INFORMATION TERMINAL, AND INFORMATION PROCESSING METHODSeptember 2019November 2021Allow2510YesNo
16582673SYSTEMS AND METHODS FOR DEVICE INVENTORY MANAGEMENT AND TRACKINGSeptember 2019September 2022Allow3621YesNo
16581578ACTIONS BASED ON CUSTOMER PREMISES DATASeptember 2019October 2022Abandon3610NoNo
16579285AUTOMATED HEALTH DATA ACQUISITION, PROCESSING AND COMMUNICATION SYSTEM AND METHODSeptember 2019August 2021Allow2310NoNo
16577755INFORMATION PROCESSING APPARATUS, MEDICAL IMAGE DISPLAY APPARATUS, AND STORAGE MEDIUMSeptember 2019June 2023Abandon4540YesNo
16570942MULTIMODAL LEARNING FRAMEWORK FOR ANALYSIS OF CLINICAL TRIALSSeptember 2019February 2021Allow1720YesNo
16562286SYSTEMS AND METHODS FOR AUTOMATED MEDICAL IMAGE ANALYSISSeptember 2019February 2023Allow4120NoNo
16554907Programmed Computer with Anti-Depression ToolsAugust 2019September 2022Allow3720NoNo
16556010SYSTEM AND METHODS FOR ENHANCED RISK ADJUSTMENT FACTOR PREDICTIONAugust 2019December 2022Abandon3921NoNo
16544775MEDICATION ORDER PROCESSING AND RECONCILIATIONAugust 2019March 2021Allow1810NoNo
16486378Neurological Data ProcessingAugust 2019August 2022Allow3621NoNo
16532086EMERGENCY DEPARTMENT COMMUNICATION SYSTEMAugust 2019March 2021Allow1921NoNo
16529842SYSTEMS AND METHODS FOR IMPROVED ANALYSIS AND GENERATION OF MEDICAL IMAGING REPORTSAugust 2019April 2022Allow3320YesNo
16527120REAL-TIME SYMPTOM ANALYSIS SYSTEM AND METHODJuly 2019June 2023Abandon4620NoYes
16452219SYSTEM FOR SECURELY TRANSMITTING MEDICAL RECORDS AND FOR PROVIDING A SPONSORSHIP OPPORTUNITYJune 2019April 2021Allow2210NoNo
16448907ELECTRONIC DEVICES AND METHODS FOR TREATMENT UTILIZING ANTIPSYCHOTICS IN COMBINATION WITH DIGITAL THERAPIESJune 2019September 2024Abandon6041YesYes
16447107SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVESJune 2019July 2023Allow4931NoNo
16471749Sample preservation container, system for processing information relating to a sample, and sample analysis processJune 2019August 2022Abandon3801NoNo
16444742GENERATING DATA IN STANDARDIZED FORMATS AND PROVIDING RECOMMENDATIONSJune 2019January 2023Allow4330NoNo
16440708METHODS FOR LOWERING TRIGLYCERIDE LEVELS WITH A CONCENTRATED FISH OIL-BASED PHARMACEUTICAL COMPOSITIONJune 2019December 2021Abandon3001NoNo
16439559MONITORING ADHERENCE TO A MEDICATION REGIMEN USING A SENSORJune 2019July 2021Abandon2501NoNo
16432529OPTIMAL MULTI-ELECTRODE TRANSCUTANEOUS STIMULATION WITH HIGH FOCALITY AND INTENSITYJune 2019March 2023Allow4511NoNo
16432846SYSTEM AND METHOD FOR ASSIGNING A CANNABIDIOL POINT VALUE AND RECOMMENDING CANNABIDIOL-INFUSED EDIBLES BASED ON BIOLOGICAL PARAMETERS AND ACTIVITY INFORMATIONJune 2019February 2023Allow4441YesNo
16430397METHODS AND SYSTEMS FOR SELECTING AN ALIMENTARY TRANSFER DESCRIPTOR USING CATEGORICAL CONSTRAINTSJune 2019October 2020Allow1620YesNo
16377968OMIC DATA AGGREGATION WITH DATA QUALITY VALUATIONApril 2019December 2020Abandon2020YesNo
16267651PHARMACOGENETIC DRUG INTERACTION MANAGEMENT SYSTEMFebruary 2019April 2022Abandon3820YesNo
16255727IDENTIFYING PROGRAM MEMBER DATA RECORDS FOR TARGETED OPERATIONSJanuary 2019June 2020Abandon1710NoNo
16316202METHODS AND APPARATUS FOR TROUBLESHOOTING INSTRUMENT MALFUNCTIONSJanuary 2019January 2023Allow4831YesNo
16235725SYSTEMS AND METHODS FOR MANAGING CAREGIVER RESPONSIBILITYDecember 2018July 2023Allow5530YesNo
16219523APPLICATION TO WORKER COMMUNICATION INTERFACEDecember 2018April 2020Allow1600YesNo
16214081SYSTEM AND METHOD OF PHARMACEUTICAL OPERATIONS FOR POST-ACUTE CARE FACILITIES LONG-TERM CARE FACILITIESDecember 2018December 2020Allow6021NoNo
16191363UTILIZING A MACHINE LEARNING MODEL TO IDENTIFY ACTIVITIES AND DEVIATIONS FROM THE ACTIVITIES BY AN INDIVIDUALNovember 2018September 2020Allow2240YesYes
16186996SYSTEMS AND METHODS FOR DISEASE CONTROL AND MANAGEMENTNovember 2018September 2020Allow2230YesNo
16186506AUTOMATED PERSONALIZED ANNOTATION OF CLINICAL GUIDELINESNovember 2018March 2022Abandon4020NoNo
16185501TREATMENT SELECTION SUPPORT SYSTEM AND METHODNovember 2018August 2021Allow3310YesNo
16184455DIAGNOSING AND TREATING NEUROLOGICAL IMPAIRMENTSNovember 2018April 2022Allow4130YesNo
16139584SYSTEM, METHOD AND DEVICE FOR PREDICTING NEED FOR SURGICAL INTERVENTIONSeptember 2018January 2024Allow6021YesYes
16115446PET INSURANCE SYSTEM AND METHODAugust 2018November 2018Allow300YesNo
16023624PET INSURANCE SYSTEM AND METHODJune 2018February 2020Allow2010NoNo
16010284PLATFORM AND SYSTEM FOR DIGITAL PERSONALIZED MEDICINEJune 2018September 2022Abandon5120NoYes
15941884EMERGENCY DEPARTMENT COMMUNICATION SYSTEMMarch 2018June 2022Allow5131NoNo
15899978METHODS AND SYSTEM FOR IMPROVING PATIENT ENGAGEMENT VIA MEDICAL AVATARSFebruary 2018October 2020Allow3110NoNo
15878253METHODS AND SYSTEMS FOR REMOTE IMAGE PROCESSINGJanuary 2018October 2021Abandon4560YesNo
15848958SYSTEM FOR DECISION MANAGEMENTDecember 2017August 2021Allow4460YesNo
15811446IDENTIFYING PROGRAM MEMBER DATA RECORDS FOR TARGETED OPERATIONSNovember 2017February 2019Abandon1520YesNo
15784263METHOD AND SYSTEM FOR CHARACTERIZING CORTICAL STRUCTURESOctober 2017October 2020Allow3610NoNo
15784693BED/ROOM/PATIENT ASSOCIATION SYSTEMS AND METHODSOctober 2017February 2021Allow4020NoNo
15729276ACCESSING AN INTEROPERABLE MEDICAL CODEOctober 2017November 2020Allow3720YesNo
15690721System and Method for Predicting and Summarizing Medical Events from Electronic Health RecordsAugust 2017January 2024Allow6040YesNo
15688958METHOD AND SYSTEM FOR MAKING CUSTOMIZED FORMULATIONS HAVING A THIXOTROPIC HYDROCOLLOID FOR INDIVIDUALSAugust 2017May 2020Allow3310NoNo
15688970APPARATUS AND MACHINE FOR MAKING CUSTOMIZED FORMULATIONS HAVING A THIXOTROPIC HYDROCOLLOID FOR INDIVIDUALSAugust 2017May 2020Allow3210NoNo
15688994APPARATUS AND MACHINE FOR MAKING CUSTOMIZED FORMULATIONS BASED ON USER INPUTAugust 2017April 2021Allow4320YesNo
15686886APPLICATION TO WORKER COMMUNICATION INTERFACEAugust 2017September 2018Allow1310YesNo
15551331DEVICE AND METHOD FOR SEQUENTIAL POSTURE IDENTIFICATION AND AUTONOMIC FUNCTION INFORMATION ACQUISITIONAugust 2017February 2022Allow5411YesNo
15670551SYSTEMS AND METHODS FOR DISEASE CONTROL AND MANAGEMENTAugust 2017December 2018Abandon1620YesNo
15656917SYSTEMS AND METHODS FOR REMOTE VERIFICATION OF USERSJuly 2017December 2021Abandon5230NoYes
15650320PRESCRIPTION COMPATIBILITY CHECKING FOR A MEDICAL DEVICEJuly 2017March 2022Allow5621YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner REYES, REGINALD R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
44
Examiner Affirmed
38
(86.4%)
Examiner Reversed
6
(13.6%)
Reversal Percentile
25.8%
Lower than average

What This Means

With a 13.6% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
84
Allowed After Appeal Filing
11
(13.1%)
Not Allowed After Appeal Filing
73
(86.9%)
Filing Benefit Percentile
16.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 13.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner REYES, REGINALD R - Prosecution Strategy Guide

Executive Summary

Examiner REYES, REGINALD R works in Art Unit 3626 and has examined 377 patent applications in our dataset. With an allowance rate of 38.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 48 months.

Allowance Patterns

Examiner REYES, REGINALD R's allowance rate of 38.2% places them in the 7% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by REYES, REGINALD R receive 3.07 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by REYES, REGINALD R is 48 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +31.3% benefit to allowance rate for applications examined by REYES, REGINALD R. This interview benefit is in the 78% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 11.6% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.1% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 32.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 33% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 33.3% of appeals filed. This is in the 5% percentile among all examiners. Of these withdrawals, 40.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 53.0% are granted (fully or in part). This grant rate is in the 51% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.8% of allowed cases (in the 64% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 38% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.